ArticleCurrent oncology (Toronto, Ont.)2026

Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumor.

Jin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.